The first pass effect (also known as first-pass metabolism or presystemic metabolism) is a phenomenon of drug metabolism whereby the concentration of a drug, specifically when administered orally, is greatly reduced before it reaches the systemic circulation. It is the fraction of drug lost during the process of absorption which is generally related to the liver and gut wall. Notable drugs that experience a significant first-pass effect are imipramine, morphine, propranolol, buprenorphine, diazepam, midazolam, pethidine, tetrahydrocannabinol (THC), ethanol (drinking alcohol), cimetidine, lidocaine, and nitroglycerin (GTN). In contrast some drugs are enhanced in potency: for example, the effect of the most commonly considered active ingredient in cannabis, THC, is enhanced by transformation of a significant portion into 11-hydroxy-THC and thus achieves greater potency than the original THC.
First pass metabolism may occur in the liver (for propranolol, lidocaine, clomethiazole, and GTN) or in the gut (for benzylpenicillin and insulin). Cal air conditioning.
First Pass Image In China
- And, now Mac AppStore lists FirstPass with its full name, “FirstPass Image Downloader and Browser”. November 18, 2011 - Another great review for firstpass “FirstPass is a very simple program that doesn’t have a host of features you’ll never use.
- Teeth of the trap (see image in step one on reverse). Fully release the lever and the needle will retract back into the shaft. Please refer to the Instructions for Use (IFU) packaged with the product for a complete list of Warnings, Precautions and Contraindications. Step 2a Insert the needle into the lower jaw. Quick reference guide FIRSTPASS™.
After a drug is swallowed, it is absorbed by the digestive system and enters the hepatic portal system. It is carried through the portal vein into the liver before it reaches the rest of the body. The liver metabolizes many drugs, sometimes to such an extent that only a small amount of active drug emerges from the liver to the rest of the circulatory system. This first pass through the liver thus may greatly reduce the bioavailability of the drug.
First pass yield (FPY), also known as throughput yield (TPY), is defined as the number of units coming out of a process divided by the number of units going into that process over a specified period of time.
An example of a drug where first pass metabolism is a complication and disadvantage is the COVID‑19 drug, remdesivir. Remdesivir cannot be orally administered because the entire dose would be trapped in the liver with little reaching the systemic circulation and reaching organs and cells affected by SARS-CoV-2. For this reason, remdesivir is administered by IV infusion, bypassing the portal vein. However, significant hepatic extraction still occurs because of second pass metabolism, whereby a fraction of venous blood travels through the hepatic portal vein and hepatocytes.
The four primary systems that affect the first pass effect of a drug are the enzymes of the gastrointestinallumen, gut wall enzymes, bacterial enzymes, and hepatic enzymes.
In drug design, drug candidates may have good druglikeness but fail on first-pass metabolism because it is biochemically selective.
Alternative routes of administration, such as suppository, intravenous, intramuscular, inhalational aerosol, transdermal, or sublingual, avoid the first-pass effect because they allow drugs to be absorbed directly into the systemic circulation.
Drugs with high first pass effect typically have a considerably higher oral dose than sublingual or parenteral dose. There is marked individual variation in the oral dose due to differences in the extent of first pass metabolism, frequently among several other factors. Oral bioavailability of many vulnerable drugs appears to be increased in patients with compromised liver function. Bioavailability is also increased if another drug competing for first pass metabolism enzymes is given concurrently (e.g., propranolol and chlorpromazine).
- ADME, an acronym in pharmacokinetics and pharmacology standing for absorption, distribution, metabolism, and excretion
- ^Rowland, Malcolm (January 1972). 'Influence of route of administration on drug availability'. Journal of Pharmaceutical Sciences. 61 (1): 70–74. doi:10.1002/jps.2600610111. ISSN0022-3549. PMID5019220.
- ^Pond, Susan M.; Tozer, Thomas N. (January 1984). 'First-Pass Elimination'. Clinical Pharmacokinetics. 9 (1): 1–25. doi:10.2165/00003088-198409010-00001. ISSN0312-5963. PMID6362950. S2CID28006040.
- ^Bath-Hextall, Fiona (October 16, 2013). 'Understanding First Pass Metabolism'. University of Nottingham. Retrieved October 26, 2017.
- ^Yan, Victoria C.; Muller, Florian L. (2020). 'Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment'. ACS Medicinal Chemistry Letters. 11 (7): 1361–1366. doi:10.1021/acsmedchemlett.0c00316. PMC7315846. PMID32665809.
- National Library of Medicine, Toxicology Tutor II, Influence of Route of Exposure